| 000 | 03604cam a2200565 i 4500 | ||
|---|---|---|---|
| 001 | ocn890934182 | ||
| 003 | OCoLC | ||
| 005 | 20221128212717.0 | ||
| 006 | m d | ||
| 007 | cr ||||||||||| | ||
| 008 | 140715t20142014nyua ob 001 0 eng | ||
| 010 | _a 2020676542 | ||
| 040 |
_aDLC _beng _erda _cDLC _dE7B _dOCLCF _dEBLCP _dYDXCP _dD6H _dSTF _dAU@ _dN$T |
||
| 019 |
_a900005799 _a923676407 _a928195951 _a992888218 |
||
| 020 |
_a9781633216709 _q(ebook) |
||
| 020 | _a1633216705 | ||
| 020 | _z1633216667 | ||
| 020 | _z9781633216662 | ||
| 035 |
_a833073 _b(N$T) |
||
| 035 |
_a(OCoLC)890934182 _z(OCoLC)900005799 _z(OCoLC)923676407 _z(OCoLC)928195951 _z(OCoLC)992888218 |
||
| 072 | 7 |
_aHEA _x039000 _2bisacsh |
|
| 072 | 7 |
_aMED _x014000 _2bisacsh |
|
| 072 | 7 |
_aMED _x022000 _2bisacsh |
|
| 072 | 7 |
_aMED _x112000 _2bisacsh |
|
| 072 | 7 |
_aMED _x045000 _2bisacsh |
|
| 049 | _aMAIN | ||
| 245 | 0 | 0 |
_aBladder cancer : _brisk factors, emerging treatment strategies and challenges _c _h[E-Book] |
| 264 | 1 |
_aNew York : _bNova Biomedical/Nova Science Publishers, Inc., _c[2014] |
|
| 300 | _a1 online resource. | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 490 | 1 | _aCancer etiology, diagnosis and treatments | |
| 520 |
_aBladder cancer is the fifth most common form of cancer worldwide and is mainly prevalent in developed countries. It is thought to arise through two distinct pathways: the noninvasive and the invasive. The noninvasive pathway gives rise to a superficial papillary carcinoma that is characterized by activating mutations in oncogenes such as H-ras, FGFR3 and PI3K. This pathway is rarely lethal as superficial papillary carcinomas can be readily removed through transurethral resection. However, 15% of noninvasive urothelial tumors can transform into invasive carcinomas and have high recurrence 80%.-- _cSource other than Library of Congress. |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | 0 |
_tCancer stem cell (CSC) in bladder malignancy / _rJianmin Zhang _g(and two others) -- _tThe five senses in bladder cancer diagnostics / _rCaterina Gulia _g(and four others) -- _tBladder cancer in pediatric patients / _rSantiago Vallasciani _g(and four others) -- _tMulti-tasking chemoinformatic model for the efficient discovery of potent and safer anti-bladder cancer agents / _rAlejandro Speck-Planche and M. N. D. S. Cordeiro -- _tLong non coding mitochondrial RNAs as potential targets for diagnosis and therapy of bladder cancer / _rJamie Villegas _g(and ten others) -- _tHistological variants of urothelial carcinoma / _rHyung Suk Kin and Ja Hyeon Ku -- _tNovel therapeutic modalities in patients with advanced or metastatic urothelial carcinoma / _rKazumasa Matsumoto _g(and four others). |
| 588 | _aDescription based on print version record and CIP data provided by publisher. | ||
| 590 | _aMaster record variable field(s) change: 050, 082 | ||
| 650 | 0 |
_aBladder _xCancer. |
|
| 700 | 1 |
_aHaggerty, Samantha, _eeditor. |
|
| 710 | 2 | _aNova Biomedical (Publishing company) | |
| 830 | 0 | _aCancer etiology, diagnosis, and treatments. | |
| 856 | 4 | 0 |
_uhttps://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=833073 _yKingston Hospital NHS Foundation Trust OpenAthens account holders click here for access |
| 938 |
_aYBP Library Services _bYANK _n11975966 |
||
| 938 |
_aEBSCOhost _bEBSC _n833073 |
||
| 938 |
_aebrary _bEBRY _nebr10913185 |
||
| 938 |
_aProQuest Ebook Central _bEBLB _nEBL2119877 |
||
| 942 | _n0 | ||
| 994 |
_a92 _bN$T |
||
| 999 |
_c91902 _d91902 |
||